Uzuner E, Ulu GT, Grler SB et al (2022) The role of MiRNA in cancer: pathogenesis, diagnosis, and treatment
Investors believe its a $1-billion-to-$3-billion-a-year market, but hard figures are elusive, because most peptides are sold on the quasi-legal gray market
There are key differences between the two methods for treating B12 deficiency, although both aim to address the issue
The objective of this review is to outline our current understanding of T1D pathogenesis and highlight significant knowledge gaps, thereby motivating future studies to improve our understanding of the precise mechanisms linking genetic and viral risk factors in the context of T1D
To what extent systemic infusion of anti-CD20 monoclonal antibodies may deplete B cells or CD20-expressing T cells (Sabatino et al., 2019
oral), concentration, and supplier